Data / Form D filings / Trefoil Therapeutics, Inc.
Trefoil Therapeutics, Inc.: Form D filings
Trefoil Therapeutics, Inc., a biotechnology company in El Cajon, CA, filed 5 Form D notices with the SEC between 2016 and 2025. The latest, on May 7, 2025, reports $4.6 million sold of a $5 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- c/o Dodson and Dodson, 14417 Ranch Trail Drive, El Cajon, CA, 92021
- Phone
- (917) 628-8502
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1691855
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 7, 2025 | New notice | $5,000,000 | $4,559,996 | $440,004 | 16 | Apr 23, 2025 | sec.gov |
| Mar 22, 2022 | New notice | $12,000,000 | $11,970,548 | $29,452 | 14 | Mar 8, 2022 | sec.gov |
| Aug 5, 2019 | Amendment | $28,010,000 | $12,604,500 | $15,405,500 | 13 | Jul 3, 2019 | sec.gov |
| Jul 17, 2019 | New notice | $28,010,000 | $11,024,999 | $16,985,001 | 10 | Jul 3, 2019 | sec.gov |
| Dec 8, 2016 | New notice | $5,164,000 | $4,163,999 | $1,000,001 | 14 | Dec 1, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christy Shaffer | Director | |
| Stella Robertson | Director | |
| Jonathan Mow | Executive Officer | |
| Ben McGraw | Director | |
| John Fucci | Director | |
| Kseniya Simpson | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 5, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Trefoil Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.